Sign in

You're signed outSign in or to get full access.

James D. Frias

Director at CARLISLE COMPANIESCARLISLE COMPANIES
Board

About James D. Frias

Retired finance executive with deep manufacturing and M&A experience; age 68 and a continuing director of Carlisle Companies Incorporated (CSL) since February 2015, with his current term expiring in 2027 . Former CFO, Treasurer and EVP of Nucor Corporation (2010–2022) and Corporate Controller (2001–2009), and designated “Audit Committee Financial Expert”; identified strengths include international business, M&A, manufacturing, and corporate governance .

Past Roles

OrganizationRoleTenureCommittees/Impact
Nucor CorporationChief Financial Officer, Treasurer & EVPJan 2010 – Mar 2022Principal financial officer; extensive M&A, JV transactions, new facilities, commercialization of new technology
Nucor CorporationCorporate ControllerJun 2001 – Dec 2009Financial controls and accounting leadership at major steel manufacturer

External Roles

OrganizationRoleTenureNotes
No other public company directorships disclosed for Mr. Frias in CSL’s 2025 proxy .

Board Governance

AttributeDetail
IndependenceBoard determined Mr. Frias is independent under CSL standards, NYSE and SEC rules (Dec 2024 review) .
Committee Assignments (current)Audit Committee Member; Corporate Governance & Nominating Committee Member .
Prior Committee ServiceServed on Compensation Committee in 2024 (interlocks section) .
Committee ChairsNone for Mr. Frias; current chairs are Myers (Audit), Ricard (Compensation), Adams (Corporate Governance & Nominating, also Lead Independent Director) .
AttendanceEach incumbent director attended all Board and applicable committee meetings in 2024; Board held six meetings, Audit (6), Compensation (3), Corporate Governance & Nominating (2) .
Lead Independent DirectorStructure in place; Mr. Adams presides over executive sessions at every regular Board meeting .
Retirement/Refreshment PolicyMandatory resignation at annual meeting following earlier of age 72 or 18 consecutive years of service; no exemptions .
Related Person TransactionsNone in 2024; Corporate Governance & Nominating Committee oversees any such items >$120,000 .
Hedging PolicyHedging of CSL equity prohibited for directors, officers, employees and designees .

Fixed Compensation

Component2024 Amount/Terms
Annual Board Retainer (policy)$125,000; directors may elect to receive up to half in Shares; no meeting fees .
Committee Chair Fees (policy)Audit Chair $25,000; Compensation Chair $20,000; Corporate Governance & Nominating Chair (Lead Independent Director) $45,000 .
Mr. Frias – Fees Earned (Cash)$128,750 .
Other Cash/PerqsDividends on unvested restricted shares: $1,927 .

Performance Compensation

ComponentGrant DetailsVesting/Performance Conditions
Annual Director Equity Grant451 restricted shares granted on April 30, 2024; grant date fair value ≈ $175,000 .Vests on earlier of 1 year from grant or retirement under Board policy (age 72 or 18 years of service) .
Deferred Compensation (Director Plan)Directors may defer up to 100% of cash fees and restricted shares; deferrals can be credited to Share equivalent units or a fixed-rate fund .Cash deferrals always 100% vested; restricted share deferrals vest per underlying award; paid after service ends .

Note: Non-employee director equity is time-vested and not tied to operating metrics; CSL’s performance metrics (Sales, Operating Income Margin, Average Working Capital % of Sales, Earnings/Adjusted Earnings) apply to executive annual incentives, not director pay .

Other Directorships & Interlocks

CategoryDetail
Other Public Company Boards (current)None disclosed for Mr. Frias .
CSL Compensation Committee ParticipationServed as a Compensation Committee member in 2024; no interlocking relationships disclosed .

Expertise & Qualifications

  • Designated “Audit Committee Financial Expert”; prior CFO experience of multinational business .
  • Significant manufacturing, M&A, corporate governance, and international business experience .
  • Background aligns with CSL’s building products focus; brings financial controls expertise .

Equity Ownership

ItemAmountAs-of
Shares Owned3,202 (includes 451 restricted shares) .Feb 28, 2025
Share Equivalent Units9,873 (no voting power; paid in Shares after service ends) .Feb 28, 2025
Total Beneficial Ownership13,075 (less than 1%) .Feb 28, 2025
Shares Outstanding44,149,183 .Feb 28, 2025
Ownership % of Outstanding≈0.03% (13,075 / 44,149,183) .
Director Stock Ownership PolicyRequires 5× annual fee ($125k) within 5 years; as of Dec 31, 2024, all directors with ≥5 years of service met the requirement (Mr. Frias joined in 2015) .

Governance Assessment

  • Board effectiveness: Independent director with 100% attendance and dual governance roles (Audit; Corporate Governance & Nominating); prior Compensation Committee service adds pay oversight experience .
  • Alignment: Annual restricted share grants and a robust director stock ownership policy (5× retainer) support skin-in-the-game; dividends on unvested shares are modest .
  • Conflicts/Red flags: No related-person transactions in 2024; hedging prohibited; no interlocks disclosed; independence re-affirmed in Dec 2024 .
  • Shareholder signals: 2024 say-on-pay support ~88%, indicating broad investor endorsement of compensation governance; committee chair rotation and lead independent structure further strengthen oversight .
  • Refreshment: Mandatory retirement at 72 or after 18 years promotes renewal; Mr. Frias (age 68; service since 2015) remains within policy parameters .

Overall: Mr. Frias presents as a financially sophisticated, independent director with strong attendance and governance credentials, low conflict risk, and equity alignment consistent with CSL’s policies—supportive of investor confidence in Board oversight .